Waverley Pharma: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (WAVE)
Waverley Pharma is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below). The healthcare sector contains companies in biotechnology, pharmaceuticals, hospitals, home and long-term care as well as related medical equipment manufacturers and suppliers.
All data provided as-at market close October 30, 2022. The list is sorted by stocks with the greatest percentage difference between valuation and price. Waverley Pharma Waverley Pharma Inc is a specialty pharma company. It is engaged in the development and commercialization of oncology drugs. Waverley Pharma is listed under WAVE on the TSX Venture Exchange.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| SLHG-X | Skylight Health Group | 0.61 | 0 | 0 | 0 | 0 | 0 |
| WAVE-X | Waverley Pharma | 0.04 | 0 | 0 | 0 | 0 | 0 |
| KNE-X | Kane Biotech | 0.08 | 0 | 0 | 0 | 0 | 0 |
| HITI-X | High Tide | 1.98 | 0 | 0 | 0 | 0 | 0 |
| NLH-X | Nova Leap Health | 0.27 | 0 | 0 | 0 | 0 | 0 |
| PAS-X | Pascal Biosciences | 0.02 | 0 | 0 | 0 | 0 | 0 |
| ACST-X | Acasti Pharma | 0.76 | 0 | 0 | 0 | 0 | 0 |
| PINK-X | Perimeter Medical Imaging | 1.43 | 0 | 0 | 0 | 0 | 0 |
| THNK-X | Think Research | 0.36 | 0 | 0 | 0 | 0 | 0 |
| ROMJ-X | Rubicon Organics | 0.72 | 0 | 0 | 0 | 0 | 0 |
More about Waverley Pharma
Stocks in this category are held primarily for capital appreciation.
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
